Sponsors

RECENT NEWS

Cell therapy reagent kits from Applied Cells

Applied Cells has announced the launch of its MARS Ingenuity Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimised for use on Applied Cells’ proprietary MARS Bar platform.

Collaboration for better diagnostics – BD to host June symposium

Registration is now open for the Infection Diagnostics Symposium, hosted by BD, which aims to bring together professionals from the laboratory, ward and board across two days to discuss how a unified approach could improve infectious disease diagnostic pathways.

Construction begins on new CDCs in Lincolnshire

Construction work is underway for two new NHS community diagnostic centres (CDCs) in Lincolnshire as part of a £38million investment in services. The centres in Skegness and Lincoln represent a significant development in local NHS services, with the centre in Skegness believed to be the largest single NHS investment in the town in many years.

Beckman Coulter and MeMed extend diagnostics partnership

Beckman Coulter Diagnostics and MeMed, a leader in the emerging field of advanced host-response technologies, have announced the expansion of their host immune response diagnostics partnership.

MHRA launches AI Airlock to address regulation challenges

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched AI Airlock, its new regulatory sandbox for AI as a Medical Device (AIaMD). This initiative aims to address challenges for regulating medical devices that use AI.

ABHI launches manifesto for healthtech

The Association of British HealthTech Industries (ABHI) has published its manifesto which articulates a clear and actionable 10-point programme for government. This strategic blueprint is designed to harness the full potential of the sector to benefit patients, clinicians, and the UK economy.

Government publishes new five-year plan to combat AMR

The government has announced its new national action plan on antimicrobial resistance to protect people and animals from the risk of drug-resistant infections. The new document builds on the progress made in the previous five-year national action plan and supports the 20-year vision to contain and control AMR by 2040.

ESCMID Global 2024 echoes multidisciplinary calls to action

Working towards a multidisciplinary approach to navigate the future of infectious diseases was a key theme at the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2024 congress.

New vaccine could protect against future coronaviruses

Researchers have developed a vaccine that has been shown in mice to protect against a broad range of coronaviruses with potential for future disease outbreaks. This is a new approach to vaccine development called ‘proactive vaccinology’, where scientists build a vaccine before the disease-causing pathogen even emerges.

BBI and BioAgilytix partner for bioanalytical testing

BBI Solutions a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership agreement with BioAgilytix, a leading global bioanalytical laboratory. The partnership will integrate BBI’s ability to produce high-quality custom antibody reagents for a variety of testing applications with BioAgilytix’s bioanalytical testing services.

New collaboration to advance ALS research

Broken String Biosciences, a genomics company driving development of cell and gene therapies, has announced it has entered a research collaboration with the Francis Crick Institute, to further understand the development of amyotrophic lateral sclerosis (ALS).

QuidelOrtho appoints Brian Blaser as President and CEO

QuidelOrtho has announced that its Board of Directors has appointed Brian J Blaser as President and CEO. In addition, Mr. Blaser will also join the Board later this month as it expands from ten to eleven members.

FDA approves ColoSense, a new multi-target RNA colorectal cancer screening test

Geneoscopy, a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, has announced that the US Food and Drug Administration (FDA) approved its non-invasive colorectal cancer (CRC) screening test, ColoSense.

Blood diagnostics modelled on leeches

Researchers at ETH Zurich have developed a new device for taking blood samples. It works according to the leech principle and is less invasive than taking blood from the arm with a needle. It is also easy to handle and can be used by people without medical training.

Trial aims to double efficacy of prostate cancer screening

A new £42m trial called TRANSFORM is aiming to find the best way to screen men for prostate cancer and is co-funded by Prostate Cancer UK and the National Institute for Health and Care Research (NIHR). Thousands more men could be saved every year as the new trial aims to double the efficacy of prostate cancer screening.

Quest Diagnostics to acquire PathAI Diagnostics

Quest Diagnostics, and PathAI have announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases. Under the terms of a definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides anatomic and digital pathology laboratory services.

IBMS unveils awards shortlist

The Institute for Biomedical Science (IBMS) has revealed the shortlists in 12 categories for its inaugural awards. Over 100 entrants have been narrowed down to just over 50 exceptional nominees, showcasing the immense talent within the biomedical science community.

Bio-Rad further expands StarBright Dye range

Bio-Rad Laboratories has further expanded its range of StarBright dyes, now totalling 32 spanning multiple lasers. The range expands translational and immunological research capabilities by providing greater choice and flexibility in conventional and full-spectrum multicolour flow cytometry panels.

New NGS partnership for Beckman Coulter Life Sciences

Beckman Coulter Life Sciences has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications, to deliver automated liquid handling solutions that enable laboratories to streamline operations and generate consistent results.

Blood samples enhance B-cell lymphoma diagnostics and prognosis

A recently completed study indicates that circulatory protein levels can provide important information for increasingly accurate diagnoses and personalised care in patients with aggressive B-cell lymphoma.

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025